BioPharmSignal logoBioPharmSignal

Biotech News

Rani Therapeutics to Participate in the H.C. Wainwright Annual BioConnect Investor Conference

Rani Therapeutics (RANI)Rani TherapeuticsConference / presentation

SAN JOSE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the company’s management team will participate in

Related news

RANIRani Therapeutics2026-08-10 12:00 EST

Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

RANIRani Therapeutics2025-11-24 21:05 EST

Rani Therapeutics to Participate in the Evercore Healthcare Conference

View all latest news

Rani Therapeutics

Oral Biologics Delivery Rani Therapeutics develops capsules that deliver biologic drugs through the intestinal wall, seeking to replace injections with oral administration. RaniPill Platform The RaniPill capsule protects its payload during passage through the stomach and deploys a microneedle-like mechanism in the small intestine. The...

Recent company news

RANIRani Therapeutics2026-09-08 12:00 EST

Rani Therapeutics to Participate in Upcoming September Conferences

RANIRani Therapeutics2026-08-13 20:05 EST

Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update

RANIRani Therapeutics2026-08-10 12:00 EST

Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

RANIRani Therapeutics2026-08-04 12:00 EST

Rani Therapeutics Appoints Michelle Gilson to Board of Directors

RANIRani Therapeutics2026-07-20 20:05 EST

Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Stock data

Close
0.85 USD
Market cap
96.4M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States